IPSC vs PPL · rev $6.6M vs P/E 22, rev $8.46B
Century Therapeutics Inc (IPSC) versus PPL Corporation (PPL) — a side-by-side from cached financials, not a winner call.
Century Therapeutics Inc (IPSC) is a biotechnology company listed on US.
PPL Corporation (PPL) is a utilities - regulated electric company listed on NYSE.
Latest reported IPSC revenue for 2024-12-31 was $6.6M. Net income was -$126.6M. Revenue was up 194.8% from 2023-12-31 to 2024-12-31. IPSC currently screens at market cap $47.8M.
Latest reported PPL revenue for 2024-12-31 was $8.46B. Net income was $888.0M. Revenue was up 1.8% from 2023-12-31 to 2024-12-31. PPL currently screens at market cap $26.58B and trailing P/E 21.7.
IPSC currently screens at market cap $47.8M. PPL currently screens at market cap $26.58B and trailing P/E 21.7.
Not investment advice. Open the IPSC and PPL stock pages for the full models.
Not investment advice.